TRPV1 and myasthenia gravis: Another study showed that TRPV1 mediates NLRP3 inflammasome activation in MG, and TRPV1 deficiency alleviates EAE in mice by inhibiting NLRP3 inflammasome activation and reducing neuroinflammation [96].